Default company panoramic image
Logo

CARLINA Technologies

Carlina Technologies is a biopharmaceutical company specialized in the development of micro- and nano-medicines.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Angers, Pays de la Loire, France
  • Currency EUR
  • Founded July 2010
  • Employees 4
  • Website carlinatech.com

Company Summary

The company provides R&D formulation development services to the pharmaceutical, veterinary and biotechnology industries as well as it develops improved versions of first generation drugs for the treatment of cancer and diabetes using innovative encapsulation platforms.

Team

  • Default avatar
    Olivier MEYER
    President & CEO

    Current
    -President & CEO, co-founder at CARLINA Technologies S.A.S.
    Past
    -Consultant, drug delivery systems, drug development, pharmaceuticals.
    -President and Chief Executive Officer at BioxelPharma Inc.
    -Assistant Director at AstraZeneca
    -Vice-President R&D at Bioxalis Medica Inc.
    -Head of Laboratory at Transgene S.A.

    Education
    -University of California, San Francisco
    -Université Paris Sud
    -Université Pierre et Marie Curie

Advisors

  • Default avatar
    ACR (Avocats Conseils Réunis)
    Lawyer
    Unconfirmed
    Default avatar
    Caexis Audit
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    GO Capital
    Unconfirmed
    Default avatar
    Anjou Amorçage
    Unconfirmed